Items where authors include "Pratt, G."

Article

Masoud, S., Wong, K., Pitcher, D. et al. (269 more authors) (2025) Quantifying association of early proteinuria and estimated glomerular filtration rate changes with long-term kidney failure in C3 glomerulopathy and immune-complex membranoproliferative glomerulonephritis using the United Kingdom RaDaR Registry. Kidney International, 108 (3). pp. 455-469. ISSN 0085-2538

Masoud, S., Wong, K., Pitcher, D. et al. (268 more authors) (2025) Quantifying association of early proteinuria and estimated glomerular filtration rate changes with long-term kidney failure in C3 glomerulopathy and immune-complex membranous proliferative glomerulonephritis using the United Kingdom RaDaR Registry. Kidney International. ISSN 0085-2538

Wong, K., Pitcher, D., Braddon, F. et al. (299 more authors) (2024) Description and Cross-Sectional Analyses of 25,880 Adults and Children in the UK National Registry of Rare Kidney Diseases Cohort. Kidney International Reports, 9 (7). pp. 2067-2083. ISSN 2468-0249

Wong, K., Pitcher, D., Braddon, F. et al. (299 more authors) (2024) Description and cross-sectional analyses of 25,880 adults and children in the UK National Registry of rare kidney diseases cohort. Kidney International Reports, 9 (7). pp. 2067-2083. ISSN 2468-0249

Wong, K., Pitcher, D., Braddon, F. et al. (294 more authors) (2024) Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort. The Lancet, 403 (10433). pp. 1279-1289. ISSN 0140-6736

Wong, K., Pitcher, D., Braddon, F. et al. (294 more authors) (2024) Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort. The Lancet, 403 (10433). pp. 1279-1289. ISSN 0140-6736

Giles, H.V., Drayson, M.T., Kishore, B. et al. (11 more authors) (2024) Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry. Blood Cancer Journal, 14. 50. ISSN 2044-5385

Keaveney, S. orcid.org/0000-0001-7715-0750, Dragan, A., Rata, M. et al. (25 more authors) (2023) Image quality in whole-body MRI using the MY-RADS protocol in a prospective multi-centre multiple myeloma study. Insights into Imaging, 14 (1). 170.

Robbe, P. orcid.org/0000-0002-0691-1126, Ridout, K.E., Vavoulis, D.V. orcid.org/0000-0002-3984-1507 et al. (142 more authors) (2022) Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features. Nature Genetics, 54. pp. 1675-1689. ISSN 1061-4036

Ahmedzai, S.H., Snowden, J.A. orcid.org/0000-0001-6819-3476, Ashcroft, A.J. et al. (19 more authors) (2019) Patient-reported outcome results from the open-label, randomized phase III myeloma X trial evaluating salvage autologous stem-cell transplantation in relapsed multiple myeloma. Journal of Clinical Oncology, 37 (19). pp. 1617-1628. ISSN 0732-183X

Snowden, J.A. orcid.org/0000-0001-6819-3476, Greenfield, D.M., Bird, J.M. et al. (7 more authors) (2017) Guidelines for screening and management of late and long-term consequences of myeloma and its treatment. British Journal of Haematology, 176 (6). pp. 888-907. ISSN 0007-1048

McNee, G., Eales, K.L., Wei, W. orcid.org/0000-0003-1288-6999 et al. (11 more authors) (2016) Citrullination of histone H3 drives IL-6 production by bone marrow mesenchymal stem cells in MGUS and multiple myeloma. Leukemia. ISSN 0887-6924

Cook, G., Ashcroft, A.J., Cairns, D.A. et al. (17 more authors) (2016) The effect of salvage autologous stem-cell transplantation on overall survival in patients with relapsed multiple myeloma (final results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial. Lancet Haematol, 3 (7). e340-e351.

Conference or Workshop Item

Gooding, S., Royle, K.-L. orcid.org/0000-0003-0225-1199, Kazeroun, M. et al. (28 more authors) (2024) Risk Assignment Using the Myeloma Genome Project Panel: A Comparison to Standard of Care Genetic Testing within the UK-MRA RADAR Trial. In: The 66th ASH Annual Meeting, 07-10 Dec 2024, San Diego, California, United States.

Proceedings Paper

Naqvi, A, Mallouppa, E., Kurien, M. orcid.org/0000-0002-4227-9500 et al. (2 more authors) (2016) 060: Does stroke subtype influence survival in dysphagic stroke patients fed by a gastrostomy? In: International Journal of Stroke. UK Stroke Forum. Sage Publications , S36-S36.

Mallouppa, E., Naqvi, A., Kurien, M. orcid.org/0000-0002-4227-9500 et al. (2 more authors) (2016) 061: Survival outcomes in gastrostomy fed stroke patients. In: International Journal of Stroke. UK Stroke Forum 2016, 28-30 Nov 2016, Liverpool, UK. SAGE Publications , S36-S36.